Drug Profile
Research programme: vaccines - SK Bioscience
Alternative Names: NBP-607; NBP-613; NBP-614Latest Information Update: 28 Apr 2019
Price :
$50
*
At a glance
- Originator SK Chemicals
- Developer SK Bioscience
- Class Influenza virus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for preclinical development in Influenza-virus-infections in South Korea (Parenteral)
- 02 Jul 2018 SK Chemicals divested the vaccine business portfolio to a newly formed subsidiary SK Bioscience
- 24 Apr 2017 SK Chemicals is conducting preclinical development for vaccines in South Korea (SK Chemicals website, April 2017)